Overview

Dashboard News

investors brace for volatility amid improving risk sentiment and geopolitical tensions

Investors' risk appetite is improving, with the S&P 500 reaching new highs and the VIX index falling below 20. However, volatility may rise due to uncertainties surrounding the Federal Reserve's interest rate policy and ongoing geopolitical tensions in the Middle East, particularly between Israel and Iran. As the US presidential election approaches, market fluctuations are expected, prompting recommendations for investors to manage potential volatility through structured strategies and exposure to gold and oil as hedges.
Insights
United States Dollar NBC News Worldwide Inc. S&P Global Inc. CBS News Kamala Harris Neel Kashkari Benjamin Netanyahu Christopher Waller Show more
TradFi, Market Report
14:12 15.10.2024

forbion raises over 2 billion dollars for new investment funds

Forbion has successfully raised over $2.2 billion for its latest investment funds, exceeding original targets and bringing total assets under management to over 5 billion euros. The Forbion Growth Opportunities III fund focuses on later-stage biotech companies, while Forbion Ventures VII targets early-stage therapeutics startups. This fundraising follows a series of significant exits, including six investments of at least $1 billion in the past year, enabling Forbion to enhance support for its portfolio companies.
BioPharma Dive
Euro GSK plc Aiolos Bio Sander Slootweg Robbert van de Griendt
Finance & Economy, Market Report
14:10 15.10.2024

elis expands global reach in linen and hygiene services for diverse sectors

Elis, a European leader in the rental and care of linen, workwear, and hygiene equipment, serves over 400,000 clients across various sectors, including hospitality, healthcare, and retail. By the end of 2023, the company operated 434 production and distribution centers globally. UBS continues to endorse a buy recommendation for Elis.
MarketScreener
UBS SA FRA
TradFi, Market Report
14:09 15.10.2024

J&J reports strong sales growth for Tremfya and Carvykti amid patent challenges

Johnson & Johnson reported strong sales growth for its cancer therapy Carvykti and immune disease drug Tremfya in Q3, as new approvals expanded their market reach. This growth comes as the company braces for biosimilar competition to its second-best-selling drug, Stelara, expected in January 2025, which saw a 7% sales decline due to insurer rebates. J&J remains optimistic, raising its operational sales guidance for the year, with plans to expand Tremfya into Crohn’s disease and Carvykti's recent FDA approval for earlier treatment in multiple myeloma.
BioPharma Dive
United States Dollar Johnson & Johnson AbbVie Inc. Amgen Inc. USA Joe Wolk Jennifer Taubert Show more
Healthcare, Market Report
14:04 15.10.2024

French healthtech sector thrives with increased venture capital funding in 2022

The French healthtech sector demonstrated resilience in 2022, raising €2.6 billion, a 14% increase from 2021, despite a 45% drop in market capitalization. Venture capital financing, particularly in e-health, biotech, and medtech, remained robust, with €1.8 billion raised across 16 significant deals. IPOs contributed €198 million, but venture capital continued to dominate funding sources, reflecting a shift in investor focus towards bio-manufacturing and CDMO activities.
EYNews
Euro Eibe - SA FRA Show more
Finance & Economy, Market Report
14:02 15.10.2024

frazier healthcare partners acquires directmed imaging to enhance diagnostic solutions

Frazier Healthcare Partners has acquired DirectMed Imaging, a prominent provider of aftermarket parts and repairs for diagnostic imaging equipment. This partnership aims to enhance DirectMed's growth and market leadership by leveraging Frazier's extensive healthcare expertise and resources. DirectMed, which supports healthcare organizations by extending the life of imaging equipment, plans to expand its capabilities in various imaging modalities.
@businesswire
Vertiv Holdings Co Frazier Healthcare Partners LBN Medical ApS DirectMed Imaging NMS Capital LP USA DNK Brad de Koning Tanner LoRusso Kent Berkley Show more
Healthcare, Press Release
14:00 15.10.2024

Goldman Sachs raises UBS price target amid integration challenges with Credit Suisse

Goldman Sachs analyst Chris Hallam has raised his price target for UBS shares from CHF 37.10 to CHF 38.70, maintaining a "buy" rating due to higher expectations for assets under management and anticipated progress in reducing operating expenses. Zürcher Kantonalbank (ZKB) acknowledges potential risks during UBS's integration of Credit Suisse but continues to rate UBS shares as "overweight." UBS is set to release its third-quarter figures on October 30.
finanzen.ch
Swiss Franc Credit Suisse Anlagestiftung Zürcher Kantonalbank The Goldman Sachs Group, Inc. UBS SA CHE Chris Hallam Donald Trump Show more
TradFi, Market Report
13:46 15.10.2024

ubs faces tough demands in emergency plan integration with finma

UBS faces demanding requirements from FINMA to enhance its emergency plans, particularly as it integrates Credit Suisse. Experts are concerned about the potential need for state intervention in future crises, while UBS is actively collaborating with FINMA to prepare for various scenarios.
zentralplus
Credit Suisse Anlagestiftung UBS SA CHE Jan Baumann
TradFi, News Article
13:40 15.10.2024

ubs emergency plans face scrutiny amid international regulatory pressures

UBS has been criticized by the Swiss financial supervisory authority, Finma, for its inadequate emergency plans following its takeover of Credit Suisse. The bank must revise these plans by the end of 2026 to ensure an orderly wind-up in a crisis, amid increasing international pressure for stricter capital requirements and detailed separation strategies. This revision could incur costs in the hundreds of millions and impact profitability and dividend policies, but UBS is cooperating with authorities and views the review as a chance to enhance its resilience.
Nau
Swiss Franc United States Dollar Reuters Ltd. Credit Suisse Anlagestiftung UBS SA US Federal Reserve Bank of England CHE USA GBR UBS CEO Ralph Hamers Credit Suisse Finma Show more
TradFi, News Article
13:40 15.10.2024

FTC updates premerger notification rules to enhance antitrust scrutiny in healthcare

The Federal Trade Commission has finalized updates to premerger notification requirements for healthcare companies, increasing the information needed for merger and acquisition reviews. This change, the first in 45 years, aims to enhance antitrust assessments amid rising deal complexity, despite pushback from the American Hospital Association, which criticized the increased reporting burden as excessive. The new rules will take effect 90 days after publication in the federal register.
Fierce Healthcare
United States Dollar American Hospital Association USA Chad Golder Shaoul Sussman
Regulatory & Legal, Press Release
13:30 15.10.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Cryptocurrency & Blockchain Regulations Central Bank Actions Market Sentiment Analysis Banking & Investment Regulations Employment Reports Banking Regulations Corporate Responsibility & ESG Anti-Money Laundering (AML) Regulations Inflation Rates & CPI Data Blockchain Technology Adoption Hedge Funds & Private Equity Cryptocurrency Regulations Tokenomics and Crypto Economics Decentralized Finance (DeFi) Innovations Mergers & Acquisitions Emerging Startups Cryptocurrency Developments
Countries:
USA GBR CHE DEU RUS IND CHN CAN ARE FRA JPN SGP TWN ESP MYS BRA LUX KEN THA AUS
Companies:
Coinbase Global, Inc. Apple Inc. NVIDIA Corporation Solana USD Ethereum USD Tesla, Inc. Chainlink USD Bitwise Bitcoin ETF Fidelity Contrafund UBS Group AG BlackRock, Inc. MicroStrategy Inc Delta Air Lines, Inc. Kraken Energy Corp. Ripple USD USD Ripples USD Microsoft Corporation Standard Chartered PLC Novartis AG Bank of America Corporation
Currencies:
United States Dollar Euro Swiss Franc British Pound Sterling Japanese Yen Indian Rupee Swedish Krona Chinese Yuan Canadian Dollar Singapore Dollar South Korean Won New Taiwan Dollar Thai Baht Philippine Peso Russian Ruble Vietnamese Đồng
People:
Donald Trump Elon Musk Ali Martinez Cynthia Lummis Gary Gensler Joe Biden Paul Atkins Brad Garlinghouse Bill Hughes Sr Tim Scott Matt Hougan Jerome Powell Bernie Moreno Elizabeth Warren Laurent Marochini Margaret Harwood-jones Keith Ammon James Howells Jimmy Carter Dave McCormick

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings